Currently, both
the Hollow Fiber Assay and xenograft models are being
utilized for the prioritization of natural product extracts for
fractionation at NCI. Information on the regular in vivo
assays currently used by the NCI, including a detailed
description of the protocol used in the Hollow Fiber Assay,
can be obtained from the following URL